Cutler Group LP Cyma Bay Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Jan 18, 2024	SELL	$12.63 - $24.47 $25,260 - $48,940	-2,000 Reduced 55.56%	1,600 $0
Q3 2023 Nov 07, 2023	BUY	$10.86 - $17.62 $39,096 - $63,432	3,600 New	3,600 $1,000
Q2 2019 Aug 09, 2019	BUY	$6.05 - $13.66 $26,620 - $60,104	4,400 Added 2200.0%	4,600 $12,000
Q2 2018 Aug 10, 2018	BUY	$10.66 - $14.38 $2,132 - $2,876	200 New	200 $0

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.